235 related articles for article (PubMed ID: 23086943)
1. Ligand directed signaling differences between rodent and human κ-opioid receptors.
Schattauer SS; Miyatake M; Shankar H; Zietz C; Levin JR; Liu-Chen LY; Gurevich VV; Rieder MJ; Chavkin C
J Biol Chem; 2012 Dec; 287(50):41595-607. PubMed ID: 23086943
[TBL] [Abstract][Full Text] [Related]
2. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
Schattauer SS; Kuhar JR; Song A; Chavkin C
Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells.
Li J; Li JG; Chen C; Zhang F; Liu-Chen LY
Mol Pharmacol; 2002 Jan; 61(1):73-84. PubMed ID: 11752208
[TBL] [Abstract][Full Text] [Related]
4. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.
Bruchas MR; Land BB; Aita M; Xu M; Barot SK; Li S; Chavkin C
J Neurosci; 2007 Oct; 27(43):11614-23. PubMed ID: 17959804
[TBL] [Abstract][Full Text] [Related]
5. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation.
Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY
J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376
[TBL] [Abstract][Full Text] [Related]
7. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.
Bruchas MR; Macey TA; Lowe JD; Chavkin C
J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation.
Schattauer SS; Bedini A; Summers F; Reilly-Treat A; Andrews MM; Land BB; Chavkin C
J Biol Chem; 2019 Nov; 294(45):16884-16896. PubMed ID: 31575661
[TBL] [Abstract][Full Text] [Related]
9. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
10. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation.
Zhang F; Li J; Li JG; Liu-Chen LY
J Pharmacol Exp Ther; 2002 Sep; 302(3):1184-92. PubMed ID: 12183679
[TBL] [Abstract][Full Text] [Related]
11. Kinase cascades and ligand-directed signaling at the kappa opioid receptor.
Bruchas MR; Chavkin C
Psychopharmacology (Berl); 2010 Jun; 210(2):137-47. PubMed ID: 20401607
[TBL] [Abstract][Full Text] [Related]
12. Signaling events initiated by kappa opioid receptor activation: quantification and immunocolocalization using phospho-selective KOR, p38 MAPK, and K(IR) 3.1 antibodies.
Lemos JC; Roth CA; Chavkin C
Methods Mol Biol; 2011; 717():197-219. PubMed ID: 21370032
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel functionally selective κ-opioid receptor scaffolds.
White KL; Scopton AP; Rives ML; Bikbulatov RV; Polepally PR; Brown PJ; Kenakin T; Javitch JA; Zjawiony JK; Roth BL
Mol Pharmacol; 2014 Jan; 85(1):83-90. PubMed ID: 24113749
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of Kir3 following kappa-opioid receptor activation of p38 MAPK causes heterologous desensitization.
Clayton CC; Xu M; Chavkin C
J Biol Chem; 2009 Nov; 284(46):31872-81. PubMed ID: 19773548
[TBL] [Abstract][Full Text] [Related]
16. Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2.
Bruchas MR; Xu M; Chavkin C
Neuroreport; 2008 Sep; 19(14):1417-22. PubMed ID: 18766023
[TBL] [Abstract][Full Text] [Related]
17. Agonist-induced regulation and trafficking of kappa opioid receptors.
Liu-Chen LY
Life Sci; 2004 Jun; 75(5):511-36. PubMed ID: 15158363
[TBL] [Abstract][Full Text] [Related]
18. Localization of the kappa opioid receptor in lipid rafts.
Xu W; Yoon SI; Huang P; Wang Y; Chen C; Chong PL; Liu-Chen LY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1295-306. PubMed ID: 16505160
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
Li JG; Benovic JL; Liu-Chen LY
Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
[TBL] [Abstract][Full Text] [Related]
20. p38 mitogen-activated protein kinase activation in amygdala mediates κ opioid receptor agonist U50,488H-induced conditioned place aversion.
Zan GY; Wang Q; Wang YJ; Chen JC; Wu X; Yang CH; Chai JR; Li M; Liu Y; Hu XW; Shu XH; Liu JG
Neuroscience; 2016 Apr; 320():122-8. PubMed ID: 26826330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
